|
|
Build Your Online Product Catalogs?
| Product Name: |
Individualized Medication Guidance for Breast Cancer
|
| Supply Ability: |
|
| Related proudcts |
|
| Specifications |
1 |
| Price Term: |
|
| Port of loading: |
|
| Minimum Order |
|
| Unit Price: |
|
|
This test ***ects 348 genes, including HRR pathway genes. The content involves targeted breast cancer therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for breast cancer patients.
Features of Individualized Breast Cancer Medication
Applicable Population of Individualized Medication Guidance for Breast Cancer
Late-stage newly diagnosed breast cancer patients who need targeted therapy and immunotherapy.
Patients with relapsed, drug-resistant breast cancer.
Breast cancer patients who need targeted therapy and immunotherapy through liquid biopsy.
If you want to know more ***ails of breast cancer diagnosis and breast cancer genetic test, please visit our website.
CapitalBio Technology Co, Ltd. is the industrialized platform of CapitalBio Corporation and Biochip Beijing National Engineering Research Center and one of the core enterprises of Tsinghua University in the field of life and health. CapitalBio Technology was registered and established in August 2012 and had production, R&D bases and marketing operation centers for biochips, instrument and equipment in Beijing, Shanghai, Chongqing, Chengdu, Dongguan, Hong Kong (China) and San Diego and other places, with a total office area of over 150,000 ŠO and employees of over 2,000 persons.
We can also offer sorts of life sciences instruments for sale, if you have needs, please contact us. |
| Company: |
CapitalBio Technology Co., Ltd.
|
| Contact: |
Ms. capitalbio technology |
| Address: |
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing |
| Postcode: |
|
| Tel: |
86-10-69002900 |
| Fax: |
|
| E-mail: |
|
|
|
|
Home
